Adlyfe, Inc.

PRONUCLEON

Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; synthetic peptides for pharmaceutical purposes; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; contrasting agent for ultrasound diagnostic imaging;Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; assays and reagents for use in genetic research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use;Pharmaceutical research and development services, namely, assay development, compound screening, compound ad chemical identification, drug target identification and characterization, performance of human clinical trials;